VolitionRx’s (VNRX) “Buy” Rating Reaffirmed at D. Boral Capital
D. Boral Capital reaffirmed their buy rating on shares of VolitionRx (NYSE:VNRX – Free Report) in a research note published on Wednesday,Benzinga reports. The firm currently has a $5.00 price target on the stock. A number of other equities analysts also recently issued reports on the stock. StockNews.com started coverage on shares of VolitionRx in […]
D. Boral Capital reaffirmed their buy rating on shares of VolitionRx (NYSE:VNRX – Free Report) in a research note published on Wednesday,Benzinga reports. The firm currently has a $5.00 price target on the stock. A number of other equities analysts also recently issued reports on the stock. StockNews.com started coverage on shares of VolitionRx in […]
